Technology News and Research

RSS

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to June 4, 2010.

27 May 2010

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

Bio-Reference Laboratories, Inc. (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009.

27 May 2010

NOXXON Pharma closes €33 million Series D round of financing

NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

The week, May 23 to May 29, is National Biomedical/Clinical Engineering Appreciation Week and celebrations across the country are recognizing the importance of this field to improving healthcare and the contributions of its practitioners.

27 May 2010

Georgia Tech team wins top three awards in NHIN-CONNECT Code-a-Thon Challenge

Medicity, Inc. - the standard for health information exchange solutions that empower physicians, hospitals and communities to improve care coordination and collaboration - is proud to announce that a team of Georgia Tech students sponsored by Medicity took the top three awards in the recent NHIN-CONNECT Code-a-Thon Challenge in Miami.

27 May 2010

Guadalupe County Hospital to implement Phoenix's Total IT Solution featuring Medsphere's OpenVista EHR

Medsphere Systems Corporation, Phoenix Health Systems and Guadalupe County Hospital today announced Guadalupe's selection of Phoenix's Total IT Solution featuring Medsphere's OpenVista® electronic health record. Phoenix IT expertise paired with Medsphere's open-source EHR solution will enable this 10-bed Santa Rosa, N.M., acute-care hospital to secure federal stimulus support for health IT implementation while improving patient care.

27 May 2010

SonoSite signs agreement to acquire privately held Visualsonics

SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt.

27 May 2010

Teleflex signs definitive agreement to sell Rigging Services business to Houston Wire & Cable for $50M

Teleflex Incorporated, a leading global provider of medical technology products, today announced that it has entered into a definitive agreement to sell its Rigging Services business to Houston Wire & Cable Company for $50 million. The transaction is subject to customary closing conditions and is expected to close by the end of the second quarter of 2010.

27 May 2010

InfraReDx's LipiScan IVUS Coronary Imaging System to be featured at EuroPCR 2010

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.

27 May 2010

CPC seminar to explore new rules shaping pregnancy, pregnancy planning

The transformation of pregnancy into a time of expert-led 'training' for potential parents will be discussed and criticised at the final Changing Parenting Culture seminar at the University of Kent's Canterbury campus 22-23 June.

27 May 2010

Computer virus infects scientist

A scientist at the University of Reading has become the first person in the world to be infected by a computer virus.

27 May 2010

Covidien launches V-Loc 90 knotless wound closure device

Covidien, a leading global provider of healthcare products, today announced the global launch of the V-Loc 90 device, expanding its family of V-Loc absorbable wound closure devices. This latest addition to Covidien's knotless wound closure product line received 510(k) clearance from the U.S. Food and Drug Administration on May 11, 2010.

27 May 2010

Oregon State University researchers make fundamental advance in robotics

Researchers at Oregon State University have made an important fundamental advance in robotics, in work that should lead toward robots that not only can walk and run effectively, but use little energy in the process.

27 May 2010

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

The Neurological Institute at University Hospitals has been designated as a Neuroscience Center of Excellence (COE), according to the Neuroscience Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. It is the first neurological program in Ohio to receive the Stage 4 - Institute designation.

27 May 2010

New device to predict wound healing

Complex wounds affect more patients in the United States than heart attack and stroke combined. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease. There are currently no established methods for early detection of wound healing, or for precise identification of healing progress.

27 May 2010

Cordis announces launch of ExoSeal Vascular Closure Device

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device. ExoSeal(TM) incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Cordis Corporation received CE-Marking approval for ExoSeal(TM) Vascular Closure Device in May 2010.

27 May 2010

Blocking the activity of PAT proteins stops cancer cell growth: Scientists

Cancer Research UK-funded scientists have revealed that a set of proteins act as the cell's 'nose' to 'sniff out' molecules which trigger cell growth, according to research published in Oncogene today.

27 May 2010

Wireless monitoring system for people with debilitating conditions

A wireless monitoring system for people with debilitating conditions such as Parkinson's disease or chronic obstructive pulmonary disorder could allow healthcare workers to assess a patient's health and the development of their disease without hindering their movements. Details of the system are reported in the International Journal of Biomedical Engineering and Technology.

27 May 2010

Naturxan expands production and distribution capabilities to provide worldwide availability of Aquasta

Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.

27 May 2010

Technology News and Research

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

NOXXON Pharma closes €33 million Series D round of financing

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

Georgia Tech team wins top three awards in NHIN-CONNECT Code-a-Thon Challenge

Guadalupe County Hospital to implement Phoenix's Total IT Solution featuring Medsphere's OpenVista EHR

SonoSite signs agreement to acquire privately held Visualsonics

Teleflex signs definitive agreement to sell Rigging Services business to Houston Wire & Cable for $50M

InfraReDx's LipiScan IVUS Coronary Imaging System to be featured at EuroPCR 2010

CPC seminar to explore new rules shaping pregnancy, pregnancy planning

Computer virus infects scientist

Covidien launches V-Loc 90 knotless wound closure device

Oregon State University researchers make fundamental advance in robotics

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

New device to predict wound healing

Cordis announces launch of ExoSeal Vascular Closure Device

Blocking the activity of PAT proteins stops cancer cell growth: Scientists

Wireless monitoring system for people with debilitating conditions

Naturxan expands production and distribution capabilities to provide worldwide availability of Aquasta

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News